46 Results

People

  1. Chiosis
    Chiosis
  2. Sadelain
    Sadelain
  3. Scheinberg
    Scheinberg
  4. Aguirre
    Aguirre
  5. Jurcic
    Jurcic
  6. Kim
    Kim
  7. Maslak
    Maslak
  8. Mcdevitt
    Mcdevitt
  9. Moulick
    Moulick
  10. Pinilla
    Pinilla

Groups

  1. Center for Hematologic Malignancies (46)
  2. GSK Faculty (46)
  3. Hematologic Malignancies Research (46)
  4. Molecular Pharmacology and Chemistry Program Faculty (46)
  5. Sloan Kettering Institute Faculty (46)
  6. Department of Medicine (28)
  7. Hematologic Malignancies, Division of (27)
  8. Tow Center for Developmental Oncology (TCDO) (15)
  9. Adult Leukemia (14)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  1. "Center for Hematologic Malignancies"
  2. "Molecular Pharmacology and Chemistry Program Faculty"
  3. "2006"
  4. "Hematologic Malignancies Research"
  5. "Sloan Kettering Institute Faculty"
Formats
  1. Journal Article (34)
  2. Meeting Abstract (12)
Groups
  1. Center for Hematologic Malignancies (46)
  2. GSK Faculty (46)
  3. Hematologic Malignancies Research (46)
  4. Molecular Pharmacology and Chemistry Program Faculty (46)
  5. Sloan Kettering Institute Faculty (46)
  6. Department of Medicine (28)

More Groups

People
  1. Gabriela Chiosis (19)
  2. Michel Sadelain (14)
  3. David Scheinberg (13)
  4. Isabelle Riviere (6)
  5. Julia Aguirre (5)
  6. Javier Pinilla (4)

More People

Years
  1. 2006 (46)
Publications
  1. Blood (5)
  2. Current Topics in Medicinal Chemistry (3)
  3. Journal of Medicinal Chemistry (3)
  4. Abstracts of Papers of the American Chemical Society (2)
  5. Bioorganic & Medicinal Chemistry Letters (2)
  6. Cancer Biotherapy and Radiopharmaceuticals (2)

More Publications

Publishers
  1. American Chemical Society (7)
  2. American Society of Hematology (5)
  3. Nature Publishing Group (5)
  4. Bentham Science Publishers (4)
  5. Pergamon-Elsevier Science Ltd (4)
  6. Mary Ann Liebert, Inc (3)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90
    Meeting Abstract

    Moulick, K.; He, H.; Zatorska, D.; Kim, J.; Aguirre, J.; Wu, N.; She, Y.; Immormino, R.; Gewirth, D.; Chiosis, G.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Design and development of purine-scaffold inhibitors of the heat shock protein 90
    Meeting Abstract

    Chiosis, G.
    Abstracts of Papers of the American Chemical Society (2006)

    Fulltext@MSK | Save
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • A panel of artificial antigen presenting cells (AAPC) permits immediate sensitization and rapid generation of virus-specific T-cells of desired HLA restriction for adoptive immunotherapy
    Meeting Abstract

    Hasan, A. N.; Kollen, W. J.; Trivedi, D.; Selvakumar, A.; Sadelain, M.; O'Reilly, R. J.
    Blood (2006)

    Fulltext@MSK | Save
  • Repetitive non-invasive imaging of genetically modified immune and tumor cells in vivo
    Meeting Abstract

    Dobrenkov, K.; Dabrowska, M.; Shenker, L.; Vider, E.; Sadelain, M.; Ponomarev, V.
    Cytotherapy (2006)

    Fulltext@MSK | Save
  • A pilot phase II trial of a synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal residual disease
    Meeting Abstract

    Cortes, J.; Reuben, J. M.; Scheinberg, D.; Lee, B. N.; Gao, H.; Li, C.; Mazanet, R.; Jones, D.; Kantarjian, H.
    Blood (2006)

    Fulltext@MSK | Save
  • Defining Hsp90 as inhibitor of apoptosis in small cell lung cancer
    Meeting Abstract

    Chiosis, G.; Rodina, A.; Kim, J.; Aguirre, J.; Moulick, K.; Lopes, E. C.; Wu, N.; She, Y.
    EJC Supplements (2006)

    Fulltext@MSK | Save